A short review of the important studies was conducted to evaluate the potential of aerosol transmission of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The minimum size of droplets potentially carrying the SARS-CoV-2 was newly estimated and discussed in this review.

An effective method for coating textile fabrics with porous materials is proposed, and the removal rates of nitrogen oxides (NOx), sulfur oxides (SOx), and fine dust particles in the coated textile fabrics are evaluated. The textile fabrics made of polyester are used to effectively reduce fine dust particles through static electricity. Zeolite and coconut shell activated carbon are used as porous material to reduce SOx and NOx, respectively. The effects of the epoxy content and dilution solution types on the SOx removal rate of textile fabrics coated with zeolite are evaluated to determine the optimum coating conditions. In addition, the effects of external environmental conditions, such as washing and freeze thawing, on the SOx and NOx removal rates of the textile fabrics coated with porous materials using the optimum coating conditions are examined. The test results show that the SOx removal rate of textile fabrics coated with zeolite decreases with the increase in the epoxy content. The decrease is 2.9 times larger for textile fabrics coated using deionized water than those coated using isopropyl alcohol. After one wash, the SOx removal rate decreases dramatically. However, the decrease is reduced by 16% when the epoxy content ratio is increased by 0.5%. The effects of washing and freeze thawing on the SOx and NOx removal rates of textile fabrics coated using the deionized water diluted with the epoxy content ratio of 2% are minimal. Consequently, to maintain stable SOx and NOx removal rates under external environmental conditions such as washing and freeze thawing, 98% deionized water dilution and 2% epoxy content ratio are required for the optimum coating of textile fabrics with zeolite and coconut shell activated carbon.

Novel genetic and epigenetic factors involved in the development and prognosis of idiopathic pulmonary fibrosis (IPF) have been identified. We previously observed that EPB41L3 increased in the lung fibroblasts of IPF patients. Thus, we investigated the role of EPB41L3 in IPF by comparing EPB41L3 mRNA and protein expression of lung fibroblast between patients with IPF and controls. We also investigated the regulation of the epithelial-mesenchymal transition (EMT) in an epithelial cell line (A549), and the fibroblast-to-myofibroblast transition (FMT) in a fibroblast cell line (MRC5), by overexpressing and silencing EPB41L3. EPB41L3 mRNA and protein levels, as measured by RT-PCR, real-time PCR, and western blot, were significantly higher in fibroblasts derived from 14 IPF patients than in those from 10 controls. The mRNA and protein expression of EPB41L3 was upregulated during transforming growth factor-β-induced EMT and FMT. Overexpression of EPB41L3 in A549 cells using lenti-EPB41L3 transfection suppressed the mRNA and protein expression of N-cadherin and COL1A1. Treatment with EPB41L3 siRNA upregulated mRNA and protein expression of N-cadherin. Overexpression of EPB41L3 in MRC5 cells using lenti-EPB41L3 transfection suppressed mRNA and protein expression of fibronectin and α-SMA. Finally, treatment with EPB41L3 siRNA upregulated mRNA and protein expression of FN1, COL1A1, and VIM. Overall, these data strongly support an inhibitory effect of EPB41L3 on the process of fibrosis and suggest therapeutic potential of EPB41L3 as an anti-fibrotic mediator.